Author: Dr. David Lowemann

Obesity Drug Zepbound More Effective in Women

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval. All doses of tirzepatide consistently reduced weight in both women and men, researchers found. But women lost up… Read Full Article (External Site) Dr. David LowemannDr. David […]

Published on September 12, 2024

Study Finds Meds May Slow Alzheimer’s in New Way

Two monoclonal antibody treatments to slow Alzheimer’s disease, lecanemab (Leqembi) and donanemab (Kisunla), have been approved by the U.S. Food and Drug Administration over the past two years. It’s thought the drugs curb Alzheimer’s by reducing levels of toxic amyloid… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder […]

Published on September 12, 2024

High Doses of ADHD Meds Could Trigger Psychosis

Prescriptions for amphetamine stimulants to treat ADHD have increased significantly in recent years, particularly during the pandemic. Unfortunately, high doses of stimulants like Adderall can increase the risk of psychosis or mania by more than fivefold, a new study… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of […]

Published on September 12, 2024